Get the best out of your hybridoma
Hybridoma selection is usually based on the specificity and the quantity of generated monoclonal antibodies.
In some instances, highly specific and interesting mAbs are produced in low amounts, necessitating multiple production runs to obtain significant amount of material, associated to high production costs.
Up to 7-fold production increase recorded so far
To improve productivity of low yield hybridomas, we have developed an in-house optimized protocol that has shown an increase in productivity for all tested hybridomas.
Our proprietary protocol advantages
Know more about your clone productivity
We can measure the productivity of your hybridoma under normal and boosted conditions in parallel, allowing a direct comparison and determining the boosting effect of our proprietary protocol.
Get high mAb quantities
in just one production
Our proprietary protocol may increase up to 7-fold the productivity of your hybridoma.
Experience high reproducibility
Our boosted condition generates very reproducible results, which allows better planification of future productions